27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
- Veracyte Inc (NASDAQ: VCYT) has priced an upsized underwritten public offering of around 7.4 million common shares at $74 per share, with gross proceeds of approximately $550 million. Earlier, the company announced the equity offering of $400 million.
- The offer price represents a discount of around 5% from the last close price of $77.87 on Thursday.
- Underwriters have an option to purchase up to an additional 1.1 million.
- The offering is expected to close by February 9.
- Goldman Sachs and SVB Leerink are acting as joint lead book-running managers for the offering.
- The majority of the proceeds from the offering will be used to finance Decipher Biosciences acquisition.
- Price Action: VCYT shares closed 5.5% higher at $77.87 on Thursday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!